Wang Qian, Zhang Xiao-Qi, Liu Shan-Shan, Liu Xin-Yan, Lv Xiao-Jing, Zhang Lei, Lv Hong
Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, 210029, China; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Suqian Hospital of Chinese Medicine, Suqian, China.
Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, 210029, China.
Exp Cell Res. 2025 Jul 15;450(2):114630. doi: 10.1016/j.yexcr.2025.114630. Epub 2025 Jun 3.
The precise involvement of Guanine Nucleotide-Binding Protein-Like 3-Like Protein (GNL3L) in lung cancer progression and invasion remains unclear. In this study, we explored the impact and underlying mechanisms of GNL3L on the proliferation, migration, and invasion of lung adenocarcinoma (LUAD), and evaluated the therapeutic potential of targeting GNL3L. Inhibition of GNL3L expression led to a notable decrease in the in vitro proliferation, migration, and invasion of A549 and H1299 non-small cell lung cancer (NSCLC) cells. Meanwhile, GNL3L silencing could significantly reduce the tumor volume of the nude mice and improve the outcomes of tumor-bearing mice in vivo. Additionally, inhibition of GNL3L expression dramatically suppressed NF-κB activation and Slug, MMP2, and MMP9 expression. Overexpression of Slug or treatment of the GNL3L-deficient cells with NF-κB activator can partially restore the growth suppressed by GNL3L deficiency, and combined treatment with Slug overexpression and NF-κB activator could totally restore the suppressed cell growth caused by GNL3L deficiency. Moreover, the overexpression of MMP2 or MMP9 could partially enhance the reduced migration and invasion caused by GNL3L deficiency, and this GNL3L-deficiency-caused suppression of migration and invasion can be totally restored by the overexpression of MMP2 and MMP9 together. These results strongly indicated that GNL3L has the capability to activate the NF-κB and increase Slug, MMP2, and MMP9 expression, which in turn could stimulate the proliferation, migration, and invasion of lung cancer cells. NF-κB activation and Slug, MMP2, and MMP9 expression enhanced by GNL3L, leading to the promotion of proliferation, migration, and invasion of lung cancer cells, indicating the therapeutic implications and potential significance of these pathways in the progression and invasion of NSCLCs that overexpress GNL3L protein.
鸟嘌呤核苷酸结合蛋白样3样蛋白(GNL3L)在肺癌进展和侵袭中的具体作用仍不清楚。在本研究中,我们探讨了GNL3L对肺腺癌(LUAD)增殖、迁移和侵袭的影响及潜在机制,并评估了靶向GNL3L的治疗潜力。抑制GNL3L表达导致A549和H1299非小细胞肺癌(NSCLC)细胞的体外增殖、迁移和侵袭显著降低。同时,沉默GNL3L可显著减小裸鼠的肿瘤体积并改善荷瘤小鼠的体内结局。此外,抑制GNL3L表达可显著抑制NF-κB激活以及Slug、MMP2和MMP9的表达。过表达Slug或用NF-κB激活剂处理GNL3L缺陷细胞可部分恢复因GNL3L缺陷而抑制的生长,联合过表达Slug和NF-κB激活剂可完全恢复由GNL3L缺陷导致的细胞生长抑制。此外,过表达MMP2或MMP9可部分增强因GNL3L缺陷而降低的迁移和侵袭能力,同时过表达MMP2和MMP9可完全恢复由GNL3L缺陷导致的迁移和侵袭抑制。这些结果强烈表明,GNL3L具有激活NF-κB并增加Slug、MMP2和MMP9表达的能力,进而可刺激肺癌细胞的增殖、迁移和侵袭。GNL3L增强NF-κB激活以及Slug、MMP2和MMP9表达,导致肺癌细胞增殖、迁移和侵袭增加,表明这些途径在过表达GNL3L蛋白的NSCLC进展和侵袭中的治疗意义及潜在重要性。